ExodusPoint Capital Management’s Legend Biotech LEGN Stock Holding History

ExodusPoint Capital Management’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-27,202	Closed	-$1.33M	–	1798
2024 Q3	$1.33M	Buy	+27,202	New	+$1.45M	0.01%	884
2022 Q4	–	Sell	-93,744	Closed	-$3.83M	–	1902
2022 Q3	$3.83M	Buy	+93,744	New	+$4.4M	0.05%	501
2021 Q4	–	Sell	-33,932	Closed	-$1.72M	–	2407
2021 Q3	$1.72M	Buy	33,932 +16,632	+96%	+$692K	0.02%	788
2021 Q2	$710K	Buy	+17,300	New	+$588K	0.01%	1177
2020 Q4	–	Sell	-7,478	Closed	-$231K	–	2189
2020 Q3	$231K	Sell	7,478 -32,973	-82%	-$1.11M	﹤0.01%	1414
2020 Q2	$1.72M	Buy	+40,451	New	+$1.58M	0.04%	489

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

ExodusPoint Capital Management's LEGN Position: Q4 2024 in Review

ExodusPoint Capital Management sold out of Legend Biotech (LEGN) in Q4 2024, closing a stake of 27,202 shares — an estimated $1.33M sold.

ExodusPoint Capital Management first reported a position in LEGN in Q2 2020 and held it in 6 quarters. The position peaked at $3.83M in Q3 2022. 211 funds tracked by Wall St. Rank hold LEGN as of Q4 2024.

ExodusPoint Capital Management reported no remaining Legend Biotech position as of Q4 2024 after selling out during the quarter.
ExodusPoint Capital Management sold 27,202 Legend Biotech shares in Q4 2024, an estimated $1.33M.
ExodusPoint Capital Management first reported a position in Legend Biotech in Q2 2020 and held it in 6 quarters.
ExodusPoint Capital Management's Legend Biotech position peaked at $3.83M in Q3 2022.
211 funds tracked by Wall St. Rank held Legend Biotech as of Q4 2024.

Based on ExodusPoint Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.